CRNX
Price
$30.05
Change
-$0.35 (-1.15%)
Updated
Jun 26, 01:13 PM (EDT)
Capitalization
2.85B
43 days until earnings call
RNA
Price
$29.73
Change
-$0.17 (-0.57%)
Updated
Jun 26, 01:37 PM (EDT)
Capitalization
3.6B
47 days until earnings call
Interact to see
Advertisement

CRNX vs RNA

Header iconCRNX vs RNA Comparison
Open Charts CRNX vs RNABanner chart's image
Crinetics Pharmaceuticals
Price$30.05
Change-$0.35 (-1.15%)
Volume$1.5K
Capitalization2.85B
Avidity Biosciences
Price$29.73
Change-$0.17 (-0.57%)
Volume$400
Capitalization3.6B
CRNX vs RNA Comparison Chart in %
Loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRNX vs. RNA commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a Hold and RNA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (CRNX: $30.41 vs. RNA: $29.90)
Brand notoriety: CRNX and RNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 73% vs. RNA: 59%
Market capitalization -- CRNX: $2.85B vs. RNA: $3.6B
CRNX [@Biotechnology] is valued at $2.85B. RNA’s [@Biotechnology] market capitalization is $3.6B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 0 FA rating(s) are green whileRNA’s FA Score has 0 green FA rating(s).

  • CRNX’s FA Score: 0 green, 5 red.
  • RNA’s FA Score: 0 green, 5 red.
According to our system of comparison, CRNX is a better buy in the long-term than RNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 3 TA indicator(s) are bullish while RNA’s TA Score has 3 bullish TA indicator(s).

  • CRNX’s TA Score: 3 bullish, 6 bearish.
  • RNA’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, CRNX is a better buy in the short-term than RNA.

Price Growth

CRNX (@Biotechnology) experienced а -0.30% price change this week, while RNA (@Biotechnology) price change was +1.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.78%. For the same industry, the average monthly price growth was +31.36%, and the average quarterly price growth was +15.04%.

Reported Earning Dates

CRNX is expected to report earnings on Aug 08, 2025.

RNA is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+1.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RNA($3.6B) has a higher market cap than CRNX($2.85B). RNA YTD gains are higher at: 2.820 vs. CRNX (-40.524). CRNX has higher annual earnings (EBITDA): -373.49M vs. RNA (-430.35M). RNA has more cash in the bank: 1.38B vs. CRNX (1.27B). RNA has less debt than CRNX: RNA (5.97M) vs CRNX (50.8M). RNA has higher revenues than CRNX: RNA (8.93M) vs CRNX (760K).
CRNXRNACRNX / RNA
Capitalization2.85B3.6B79%
EBITDA-373.49M-430.35M87%
Gain YTD-40.5242.820-1,437%
P/E RatioN/AN/A-
Revenue760K8.93M9%
Total Cash1.27B1.38B92%
Total Debt50.8M5.97M850%
FUNDAMENTALS RATINGS
CRNX: Fundamental Ratings
CRNX
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
67
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRNXRNA
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 21 days ago
76%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 7 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VIGAX220.47N/A
N/A
Vanguard Growth Index Admiral
SBFAX29.70N/A
N/A
1919 Financial Services A
MAILX20.82N/A
N/A
BlackRock International Instl
FEIFX32.50N/A
N/A
Franklin Equity Income Adv
CTCSX37.79-0.56
-1.46%
Calamos Timpani Small Cap Growth C

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XNCR. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
-1.71%
XNCR - CRNX
58%
Loosely correlated
+3.51%
TRDA - CRNX
57%
Loosely correlated
-0.28%
IDYA - CRNX
56%
Loosely correlated
+1.06%
RVMD - CRNX
55%
Loosely correlated
-4.05%
DYN - CRNX
55%
Loosely correlated
-1.98%
More

RNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNA has been loosely correlated with ACLX. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if RNA jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNA
1D Price
Change %
RNA100%
+0.10%
ACLX - RNA
59%
Loosely correlated
+1.07%
DYN - RNA
57%
Loosely correlated
-1.98%
OCUL - RNA
51%
Loosely correlated
+1.10%
SNDX - RNA
51%
Loosely correlated
-3.47%
CRNX - RNA
51%
Loosely correlated
-1.71%
More